Zobrazeno 1 - 10
of 51
pro vyhledávání: ''
Publikováno v:
Heart (British Cardiac Society). 103(23)
Learning objectives Refractory angina (RA) is conventionally defined as a chronic condition (≥3 months in duration) characterised by angina caused by coronary insufficiency in the setting of coronary artery disease (CAD) which cannot be controlled
Autor:
Takao Kato, Yoshihisa Nakagawa, Koh Ono, Kazushige Kadota, Yutaka Furukawa, Satoshi Shizuta, Kenji Ando, Naritatsu Saito, Toshiaki Toyota, Kyohei Yamaji, Shuichiro Kaji, Minoru Horie, Takeshi Morimoto, Hiroki Shiomi, Takeshi Kimura
Publikováno v:
Heart (British Cardiac Society). 104(11)
ObjectivesTo clarify the effect of single-session multivessel percutaneous coronary intervention (PCI) strategy relative to the staged multivessel strategy on clinical outcomes in patients with stable coronary artery disease (CAD) or non-ST-elevation
Autor:
Eugenio Picano, Francesco Bovenzi, Claudio Michelassi, Rosa Sicari, Clara Carpeggiani, Lauro Cortigiani
Publikováno v:
Heart (British Cardiac Society). 104(9)
ObjectivesTo assess the value of a simple score integrating non-ischaemia-related variables in expanding the wall motion abnormalities risk power during stress echocardiography (SE).MethodsStudy includes 14 279 patients who underwent SE for evaluatio
Publikováno v:
Heart (British Cardiac Society). 103(24)
Valve thrombosis can occur in mechanical prosthetic valves and is increasingly recognised in transcatheter and surgically implanted bioprosthetic valves. The risk of thrombosis of mechanical valves is higher in the mitral position compared with aorti
Autor:
Yedid Elbez, Kim A. Eagle, Ronan Roussel, Louis Potier, Christopher M. Reid, Uwe Zeymer, Deepak L. Bhatt, Magnus Ohman, Michel Marre, Philippe Gabriel Steg
Publikováno v:
Heart (British Cardiac Society). 103(17)
ACE inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) are widely prescribed in patients with high cardiovascular (CV) risk. However, whether both classes have equivalent effectiveness to prevent CV events remains unclear. The aim of this st
Autor:
Jatinder Pabla, Asrar Ahmed, Roxy Senior, Alina Hua, Nikos Karogiannis, Grace Young, Sothinathan Gurunathan, Benoy N. Shah
Publikováno v:
Heart (British Cardiac Society). 103(7)
Introduction Although stress echocardiography (SE) is invaluable in younger populations, its prognostic value may be attenuated in the elderly due to shorter life expectancy and the frequent presence of severe comorbidities. This study sought to eval
Autor:
Howard I. Kurz, Marc Sintek, Richard G. Bach, Christopher T. Sparrow, Jasvindar Singh, Ted R. Mikuls, Eric Novak, Kathyrn J Lindley
Publikováno v:
Heart (British Cardiac Society). 102(5)
Objective To investigate repeat revascularisation outcomes in patients with rheumatoid arthritis(RA) after percutaneous coronary intervention (PCI). Methods We performed a single-centre, retrospective matched cohort study of patients with RA matched
Autor:
Jean-Pierre Després, Ewa Ninio, Mélanie Côté, Jamal S. Rana, Kay-Tee Khaw, J.J.P. Kastelein, S.M. Boekholdt, M. S. Sandhu, Aeilko H. Zwinderman, Philippa J. Talmud, Nicholas J. Wareham
Publikováno v:
Heart, 95(20), 1682-1687. BMJ Publishing Group
Heart (British Cardiac Society), 95(20), 1682-1687. BMJ Publishing Group
Heart (British Cardiac Society), 95(20), 1682-1687. BMJ Publishing Group
Objective: To evaluate the role of the inflammatory biomarkers C-reactive protein (CRP), myeloperoxidase, paraoxonase, secretory phospholipase A2 group IIA (sPLA2), lipoprotein-associated phospholipase A2, fibrinogen, macrophage chemoattractant prote
Publikováno v:
Heart (British Cardiac Society). 101(7)
Objective The purpose of our study was to determine whether sex affects the predictive value of perfusion and wall motion imaging obtained with real time myocardial contrast echocardiography (RTMCE) when compared with conventional stress echocardiogr
Autor:
Isabella Kardys, Victor A. Umans, Patrick W. Serruys, Ron T. van Domburg, Stephan Windecker, Michael Magro, Eric Boersma, Robbert-Jan van Geuns, K. Martijn Akkerhuis, Nick van Boven, Lorenz Räber
Publikováno v:
Heart, 101(1), 50-57. BMJ Publishing Group
Objective Everolimus drug-eluting stents (EES) are superior to early-generation drug-eluting stents (DES), releasing sirolimus (SES) or paclitaxel (PES) in preventing stent thrombosis (ST). Since an impaired LVEF seems to increase the risk of ST, we